BibTex RIS Cite

-

Year 2005, Volume: 18 Issue: 2, 71 - 75, 29.06.2015

Abstract

-

References

  • 1. Akman İ, Cebeci D, Özek E, İmamoğlu S. Effects of perinatal factors on the duration and cost of hospitalization for premature infants at a university hospital in Istanbul. Turk J Med Sci.2002;32:159-163.
  • 2. Joffe S, Escobar GJ, Black SB, Armstrong MA. Rehospitalization for respiratory syncytial virus among premature infants.Pediatrics :1999;10:894- 899.
  • 3. Nachman AS, Waliser M, Qureshi MZ. Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge : A 3-year follow up. Pediatrics 1997;100:E8
  • 4. Chien Y, Tsao P, Chou H, Tang J, Tsou K. Rehospitalization of extremely low birth weight infants in first 2 years of life. Early human development. 2002;66:33-40.
  • 5. Cunningham CK, Mc Millan JA, Gross SJ. Rehospitalization for respiratory illnes in infants of less than 32 weeks gestation. Pediatrics. 1991;88,527- 532.
  • 6. IMpact – RSV study group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102: 531-537.
  • 7. The PREVENT study group. Reduction of respiratory syncytial virus hospitalisation among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-99.
  • 8. Stout AU, Stout TJ. Retinopathy of prematurity Pediatr Clin of North Am 2003;50:77-87
  • 9. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterms. Arch Dis Child Fetal Neonatal Ed. 2003;88:F41-F45.
  • 10. Calhoun DA, Christensen RD, Edstorm CS, et al: Consistent aproaches to procedures and practices in neonatal hematology. Clin Perinatol 2000;27:733-753
  • 11. American Academy of Pediatrics. Respiratory Syncytial Virus In: Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases 25th ed. Erk Grove Village, IL: 2000:483-487
  • 12. Chye JK, Gray PH. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 1995;31:105- 111
  • 13. Darlow BA, Cust AE, Donoghue DA. Improved outcomes for very low birth weight infants: evidence from New Zeland national population based data. Arch Dis Child Fetal Neonatal Ed. 2002;88:F23-F28
  • 14. Ohls RK , The use of erythropoietin in neonates. Clin Perinatol.2000;27:681-696
  • 15. Andersen C: Critical hemoglobin tresholds in premature infants. Arch Dis Child Fetal Neonatal Ed. 2001;84:F146-F148
  • 16. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birth weight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed. 2001;84:F96-F100
  • 17. Kling JP, Winzerling J. Iron status and treatment of the anemia of prematurity. Clin Perinatol 2002;29: 283-294
  • 18. Al-Kharfy T, Smyth JA, Wasworth L, et al: Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996;129(1):89-96
  • 19. Kumar P, Shankaran S, Krishnan RG: Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: A randomized, double blind, placebo controlled trial. J Perinatol 1998;18(3):173-177
  • 20. Maier RF, Obladen M, Scigalla P et al The effect of erythropoetin beta (recombinant human erythropoietin ) on the need for transfusion in very low birth weight infants.European Multicentre Erythropoietin Study Group. N Engl J Med 1994;330(17):1173-1178
  • 21. Shannon KM, Keith JF, Mentzner WC et al Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95(1):1-8
  • 22. Ohls RK, Ehrenkranz RA, Lemons JA et al: A multi centered, randomized, double blind, placebo controlled trial of erythropoietin administration to premature infants
  • 23. Atasay B, Gunlemez A, Akar N, Arsan S. Does early erytropoietin therapy decrease transfusions in anemia of prematurity? Indian J Pediatr. 2002; 69:389-391
  • 24. Seidman DS, Stevenson DK, Ergaz Z, Gale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 1995:96: 727-729

DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI

Year 2005, Volume: 18 Issue: 2, 71 - 75, 29.06.2015

Abstract

Amaç: Preterm bebekler taburculuk sonrasında tekrar hastaneye yatış açısından risk altındadırlar. Bu çalışmada rehospitalizasyon riskini arttıran perinatal faktörleri, rehospitalizasyon nedenlerini, ortalama süresini belirlemeyi amaçladık.

Yöntem: Marmara Üniversitesi Hastanesi Yenidoğan Yoğunbakım Ünitesinde 1998-2002 arasında izlenmiş olan gestasyon yaşı 32 haftadan düşük 73 yenidoğanın ve 100 term yenidoğanın kayıtları retrospektif olarak incelendi.

Bulgular: Bir yıllık takip süresinde preterm yenidoğanların %53’ü (n=32) en az bir kez, %20’si (n=12) birden fazla kez, term yenidoğanların %5’i (n=5) rehospitalize edilmiştir. Rehospitalize edilmiş yada edilmemiş olan yenidoğanların sepsis, intravenriküler kanama, bronkopulmoner displazi, respiratuar distres sendromu gibi perinatal faktörleri, gestasyon yaşı, doğum ağırlığı, cinsiyeti benzer saptanmıştır. Çok düşük doğum ağırlıklı olmak hastaneye yatış için riski bulunmuştur (85.7% karşılık 14.3%), (p=0.02). Prematürelerde en sık rehospitalizasyon nedenleri prematurite anemisi, solunum sistemi hastalıkları ve idrar yolu enfeksiyonu olmakla beraber term yenidoğanlarda en sık neden sarılık olarak saptanmıştır.

Sonuç: Preterm doğanlar taburcu edildikten sonra tekrar hastaneye yatışa sebep olabilecek değişik sağlık sorunları ile karşılaşmaktadır ve tekrar yatış oranları yüksektir.

Anahtar Kelimeler: Rehospitalizasyon, Preterm, Prematüre anemisi

References

  • 1. Akman İ, Cebeci D, Özek E, İmamoğlu S. Effects of perinatal factors on the duration and cost of hospitalization for premature infants at a university hospital in Istanbul. Turk J Med Sci.2002;32:159-163.
  • 2. Joffe S, Escobar GJ, Black SB, Armstrong MA. Rehospitalization for respiratory syncytial virus among premature infants.Pediatrics :1999;10:894- 899.
  • 3. Nachman AS, Waliser M, Qureshi MZ. Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge : A 3-year follow up. Pediatrics 1997;100:E8
  • 4. Chien Y, Tsao P, Chou H, Tang J, Tsou K. Rehospitalization of extremely low birth weight infants in first 2 years of life. Early human development. 2002;66:33-40.
  • 5. Cunningham CK, Mc Millan JA, Gross SJ. Rehospitalization for respiratory illnes in infants of less than 32 weeks gestation. Pediatrics. 1991;88,527- 532.
  • 6. IMpact – RSV study group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102: 531-537.
  • 7. The PREVENT study group. Reduction of respiratory syncytial virus hospitalisation among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-99.
  • 8. Stout AU, Stout TJ. Retinopathy of prematurity Pediatr Clin of North Am 2003;50:77-87
  • 9. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterms. Arch Dis Child Fetal Neonatal Ed. 2003;88:F41-F45.
  • 10. Calhoun DA, Christensen RD, Edstorm CS, et al: Consistent aproaches to procedures and practices in neonatal hematology. Clin Perinatol 2000;27:733-753
  • 11. American Academy of Pediatrics. Respiratory Syncytial Virus In: Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases 25th ed. Erk Grove Village, IL: 2000:483-487
  • 12. Chye JK, Gray PH. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 1995;31:105- 111
  • 13. Darlow BA, Cust AE, Donoghue DA. Improved outcomes for very low birth weight infants: evidence from New Zeland national population based data. Arch Dis Child Fetal Neonatal Ed. 2002;88:F23-F28
  • 14. Ohls RK , The use of erythropoietin in neonates. Clin Perinatol.2000;27:681-696
  • 15. Andersen C: Critical hemoglobin tresholds in premature infants. Arch Dis Child Fetal Neonatal Ed. 2001;84:F146-F148
  • 16. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birth weight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed. 2001;84:F96-F100
  • 17. Kling JP, Winzerling J. Iron status and treatment of the anemia of prematurity. Clin Perinatol 2002;29: 283-294
  • 18. Al-Kharfy T, Smyth JA, Wasworth L, et al: Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996;129(1):89-96
  • 19. Kumar P, Shankaran S, Krishnan RG: Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: A randomized, double blind, placebo controlled trial. J Perinatol 1998;18(3):173-177
  • 20. Maier RF, Obladen M, Scigalla P et al The effect of erythropoetin beta (recombinant human erythropoietin ) on the need for transfusion in very low birth weight infants.European Multicentre Erythropoietin Study Group. N Engl J Med 1994;330(17):1173-1178
  • 21. Shannon KM, Keith JF, Mentzner WC et al Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95(1):1-8
  • 22. Ohls RK, Ehrenkranz RA, Lemons JA et al: A multi centered, randomized, double blind, placebo controlled trial of erythropoietin administration to premature infants
  • 23. Atasay B, Gunlemez A, Akar N, Arsan S. Does early erytropoietin therapy decrease transfusions in anemia of prematurity? Indian J Pediatr. 2002; 69:389-391
  • 24. Seidman DS, Stevenson DK, Ergaz Z, Gale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 1995:96: 727-729
There are 24 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Elif Karakoç Aydıner This is me

İpek Özkan Akman This is me

Sibel Kalaça This is me

Tamer Ünver This is me

Hülya Bilgen This is me

Eren Özek This is me

Publication Date June 29, 2015
Published in Issue Year 2005 Volume: 18 Issue: 2

Cite

APA Karakoç Aydıner, E., Özkan Akman, İ., Kalaça, S., Ünver, T., et al. (2015). DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI. Marmara Medical Journal, 18(2), 71-75.
AMA Karakoç Aydıner E, Özkan Akman İ, Kalaça S, Ünver T, Bilgen H, Özek E. DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI. Marmara Med J. August 2015;18(2):71-75.
Chicago Karakoç Aydıner, Elif, İpek Özkan Akman, Sibel Kalaça, Tamer Ünver, Hülya Bilgen, and Eren Özek. “DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI”. Marmara Medical Journal 18, no. 2 (August 2015): 71-75.
EndNote Karakoç Aydıner E, Özkan Akman İ, Kalaça S, Ünver T, Bilgen H, Özek E (August 1, 2015) DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI. Marmara Medical Journal 18 2 71–75.
IEEE E. Karakoç Aydıner, İ. Özkan Akman, S. Kalaça, T. Ünver, H. Bilgen, and E. Özek, “DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI”, Marmara Med J, vol. 18, no. 2, pp. 71–75, 2015.
ISNAD Karakoç Aydıner, Elif et al. “DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI”. Marmara Medical Journal 18/2 (August 2015), 71-75.
JAMA Karakoç Aydıner E, Özkan Akman İ, Kalaça S, Ünver T, Bilgen H, Özek E. DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI. Marmara Med J. 2015;18:71–75.
MLA Karakoç Aydıner, Elif et al. “DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI”. Marmara Medical Journal, vol. 18, no. 2, 2015, pp. 71-75.
Vancouver Karakoç Aydıner E, Özkan Akman İ, Kalaça S, Ünver T, Bilgen H, Özek E. DÜŞÜK DOĞUM AĞIRLIKLI YENİDOĞANLARDA YAŞAMLARININ İLK BİR YILINDA REHOSPİTALİZASYON ORANLARI. Marmara Med J. 2015;18(2):71-5.